Brokerages expect Encompass Health Corp (NYSE:EHC) to post earnings of $0.92 per share for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Encompass Health’s earnings, with the lowest EPS estimate coming in at $0.87 and the highest estimate coming in at $0.96. Encompass Health posted earnings per share of $0.93 during the same quarter last year, which suggests a negative year-over-year growth rate of 1.1%. The business is scheduled to report its next quarterly earnings report on Thursday, April 25th.
According to Zacks, analysts expect that Encompass Health will report full year earnings of $3.77 per share for the current year, with EPS estimates ranging from $3.71 to $3.88. For the next year, analysts forecast that the company will report earnings of $3.93 per share, with EPS estimates ranging from $3.75 to $4.07. Zacks Investment Research’s EPS averages are a mean average based on a survey of analysts that that provide coverage for Encompass Health.
EHC has been the topic of a number of recent research reports. UBS Group initiated coverage on shares of Encompass Health in a research note on Thursday, November 15th. They issued a “buy” rating and a $86.00 price objective on the stock. ValuEngine raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Monday, February 4th. Jefferies Financial Group assumed coverage on shares of Encompass Health in a report on Thursday, December 20th. They issued a “buy” rating for the company. Finally, Barclays assumed coverage on shares of Encompass Health in a report on Friday, December 14th. They issued an “equal weight” rating and a $75.00 target price for the company. One investment analyst has rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $74.88.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Featured Article: 52-Week High/Low Prices For Stock Selection
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.